All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14)

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F19%3AA20021Q9" target="_blank" >RIV/61988987:17110/19:A20021Q9 - isvavai.cz</a>

  • Alternative codes found

    RIV/00843989:_____/19:E0107410

  • Result on the web

    <a href="https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.25331" target="_blank" >https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ajh.25331</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1002/ajh.25331" target="_blank" >10.1002/ajh.25331</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14)

  • Original language description

    To the Editor: Plasma cell leukemia (PCL) is the most aggressive form of plasma cell dyscrasia. It is characterized by the presence of more than 20% and/or more than 2 × 109 /L of circulating plasma cells (PCs). Primary plasma cell leukemia (pPCL) that presents de novo should be distinguished from secondary PCL, which corresponds to the leukemic transformation of pre-existing multiple myeloma (MM). Primary PCL is characterized by an increased frequency of adverse laboratory and clinical features as well as higher genetic instability than MM. Despite the introduction of novel agents into clinical practice, the prognosis of pPCL remains poor, with an estimated overall survival of 1-2 years in elderly patients and about 3 years in younger patients eligible for stem cell transplantation (SCT).1,2

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30205 - Hematology

Result continuities

  • Project

  • Continuities

    S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2019

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    AMERICAN JOURNAL OF HEMATOLOGY

  • ISSN

    0361-8609

  • e-ISSN

    1096-8652

  • Volume of the periodical

    94

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    2

  • Pages from-to

    'E35'-'E37'

  • UT code for WoS article

    000453909800019

  • EID of the result in the Scopus database

    2-s2.0-85057288241